|
|||
| 1 | A bill to be entitled | ||
| 2 | An act relating to public records; exempting from public | ||
| 3 | records requirements information and records reported to | ||
| 4 | the Department of Health under the electronic monitoring | ||
| 5 | system for prescription of controlled substances listed in | ||
| 6 | Schedules II-IV; authorizing certain persons and entities | ||
| 7 | access to patient-identifying and practitioner-identifying | ||
| 8 | information; providing guidelines for the use of such | ||
| 9 | information and penalties for violations; providing for | ||
| 10 | future legislative review and repeal; providing a finding | ||
| 11 | of public necessity; providing a contingent effective | ||
| 12 | date. | ||
| 13 | |||
| 14 | Be It Enacted by the Legislature of the State of Florida: | ||
| 15 | |||
| 16 | Section 1. (1)(a) A patient's personal identifying | ||
| 17 | information contained in any record reported under s. 893.055, | ||
| 18 | Florida Statutes, is confidential and exempt from the provisions | ||
| 19 | of s. 119.07(1), Florida Statutes, and s. 24(a), Art. I of the | ||
| 20 | State Constitution. | ||
| 21 | (b) This section is subject to the Open Government Sunset | ||
| 22 | Review Act of 1995 in accordance with s. 119.15, Florida | ||
| 23 | Statutes, and shall stand repealed on October 2, 2010, unless | ||
| 24 | reviewed and saved from repeal through reenactment by the | ||
| 25 | Legislature. | ||
| 26 | (2) The Department of Health may disclose a patient's or | ||
| 27 | practitioner's identity in the information or records reported | ||
| 28 | under s. 893.055, Florida Statutes, whose identity is otherwise | ||
| 29 | confidential and exempt from the provisions of s. 119.07(1), | ||
| 30 | Florida Statutes, and s. 24(a), Art. I of the State | ||
| 31 | Constitution, to the following: | ||
| 32 | (a) A practitioner defined under chapter 893, Florida | ||
| 33 | Statutes, who requests information and certifies that the | ||
| 34 | information is necessary to provide medical treatment in | ||
| 35 | accordance with s. 893.05, Florida Statutes, to a current | ||
| 36 | patient, subject to the patient's written consent. The | ||
| 37 | practitioner may designate one person in his or her office to | ||
| 38 | access the information and records reported under s. 893.055, | ||
| 39 | Florida Statutes, on the practitioner's patients and provide | ||
| 40 | information to the practitioner as directed, subject to the | ||
| 41 | patient's written consent. | ||
| 42 | (b) A pharmacist licensed in this state, or a pharmacy | ||
| 43 | intern or pharmacy technician designated by the pharmacist, who | ||
| 44 | requests information and certifies that the requested | ||
| 45 | information is to be used to dispense controlled substances in | ||
| 46 | accordance with s. 893.04, Florida Statutes, to a current | ||
| 47 | patient. | ||
| 48 | (c) A criminal justice agency defined under s. 119.011, | ||
| 49 | Florida Statutes, which enforces the laws of this state or the | ||
| 50 | United States relating to drugs and which is engaged in a | ||
| 51 | specific investigation involving a violation of law. Any member | ||
| 52 | of a criminal justice agency receiving the information as | ||
| 53 | authorized in this section shall avoid unauthorized use or | ||
| 54 | dissemination thereof. Such member receiving the information may | ||
| 55 | disclose its contents to other persons to the extent that such | ||
| 56 | disclosure is appropriate to the proper performance of the | ||
| 57 | official duties of the member making or the person receiving the | ||
| 58 | disclosure. | ||
| 59 | (d) An employee or agent of the Department of Health who | ||
| 60 | is involved in a specific investigation involving a violation of | ||
| 61 | the chapter regulating the alleged violator, the rules of the | ||
| 62 | Department of Health, or the rules of a board regulating the | ||
| 63 | alleged violator. | ||
| 64 | (e) An employee of the Agency for Health Care | ||
| 65 | Administration who is involved in an investigation related to | ||
| 66 | the agency's responsibility to control fraud and abuse in the | ||
| 67 | Medicaid program. | ||
| 68 | (3)(a) A person who obtains information under this section | ||
| 69 | may not use the information to his or her own personal advantage | ||
| 70 | or reveal any information obtained in the enforcement of law | ||
| 71 | except in a prosecution or administrative hearing for a | ||
| 72 | violation of state or federal law or, if applicable, to provide | ||
| 73 | medical treatment in accordance with s. 893.05, Florida | ||
| 74 | Statutes, to a current patient or to dispense controlled | ||
| 75 | substances in accordance with s. 893.04, Florida Statutes, to a | ||
| 76 | current patient, or to the patient for verifying the accuracy of | ||
| 77 | such information. | ||
| 78 | (b) Any person who knowingly violates this subsection | ||
| 79 | commits a felony of the third degree, punishable as provided in | ||
| 80 | s. 775.082 or s. 775.083, Florida Statutes. | ||
| 81 | (4) A practitioner or pharmacist authorized to obtain | ||
| 82 | information under this section is not liable for accessing or | ||
| 83 | failing to access such information. | ||
| 84 | (5) A practitioner, pharmacist, or other person or agency | ||
| 85 | that obtains information reported under s. 893.055, Florida | ||
| 86 | Statutes, must maintain the confidentiality of such information | ||
| 87 | pursuant to ss. 456.057 and 465.017, Florida Statutes, or as | ||
| 88 | otherwise required by law. | ||
| 89 | Section 2. The Legislature finds that it is a public | ||
| 90 | necessity that personal identifying information reported to the | ||
| 91 | Department of Health under s. 893.055, Florida Statutes, be held | ||
| 92 | confidential and exempt from disclosure because doing so will | ||
| 93 | facilitate efforts to maintain compliance with the state's drug | ||
| 94 | laws not only by patients through accurate and timely reporting | ||
| 95 | by health care practitioners and pharmacists of potential drug | ||
| 96 | diversion without compromising a patient's privacy, with certain | ||
| 97 | exceptions, but also by persons authorized to prescribe or | ||
| 98 | dispense controlled substances through oversight review and | ||
| 99 | investigation of improper prescribing and dispensing practices. | ||
| 100 | The exemption for a patient's identity in the information or | ||
| 101 | records reported under s. 893.055, Florida Statutes, facilitates | ||
| 102 | the sharing of information between health care practitioners and | ||
| 103 | pharmacists so that the practitioners and pharmacists may | ||
| 104 | appropriately identify and evaluate a patient's risk for drug | ||
| 105 | diversion and the resulting abuse of controlled substances | ||
| 106 | without compromising a patient's privacy. The Legislature | ||
| 107 | further finds that the exemption for records identifying a | ||
| 108 | patient or practitioner within information or records reported | ||
| 109 | to the Department of Health is a public necessity to protect | ||
| 110 | health-related information of a sensitive and personal nature. | ||
| 111 | Matters of personal health are traditionally private and | ||
| 112 | confidential concerns between a patient and a health care | ||
| 113 | provider. The private and confidential nature of personal health | ||
| 114 | matters pervades both the public and private health care | ||
| 115 | sectors. For these reasons, an individual's expectation of a | ||
| 116 | right to privacy in all matters regarding his or her personal | ||
| 117 | health necessitates such exemption. Information relating to | ||
| 118 | practitioners prescribing or dispensing controlled substances | ||
| 119 | needs to be kept confidential for criminal justice agencies and | ||
| 120 | regulatory agencies and departments to properly investigate | ||
| 121 | potentially improper prescribing or dispensing practices that | ||
| 122 | indicate drug diversion by such practitioners or contributing to | ||
| 123 | drug diversion by a patient without compromising the livelihood | ||
| 124 | of such practitioner with unsubstantiated charges of improper | ||
| 125 | dispensing or prescribing practice. For these reasons, a | ||
| 126 | practitioner's expectation of a right to privacy in the review | ||
| 127 | and investigation of unsubstantiated charges affecting his or | ||
| 128 | her livelihood necessitates such exemption. | ||
| 129 | Section 3. This act shall take effect July 1, 2005, if | ||
| 130 | House Bill 397 or similar legislation establishing an electronic | ||
| 131 | system to monitor the prescribing of controlled substances is | ||
| 132 | adopted in the same legislative session or an extension thereof | ||
| 133 | and becomes law. | ||